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Abstract
Little attention has been paid to the fact that intensity modulated radiation therapy (IMRT) techniques do not
easily enable treatment with opposed beams. Three treatment plans (3 D conformal, IMRT, and combined (anterior-
posterior-posterio-anterior (AP-PA) + IMRT) of 7 patients with centrally-located lung cancer were compared for
exposure of lung, spinal cord and esophagus. Combined IMRT and AP-PA techniques offer better lung tissue
sparing compared to plans predicated solely on IMRT for centrally-located lung tumors.
Keywords: Lung cancer, Radiation, IMRT, 3D, AP-PA
Background
Lung cancer constitutes a major source of mortality in
the western world. The disease is usually diagnosed in
advanced stages. Locally advanced disease represents
22% of newly diagnosed cases and is typically associated
with 5 year relative survival rates of 24% [1]. External
beam radiation therapy is the essential component in
the treatment of stage 3 Non Small Cell Lung Cancer
(NSCLC) and Small Cell Lung Cancer (SCLC) patients.
Definitive radiation concurrent with chemotherapy is
the standard of care of stage 3 NSCLC. Recommended
doses of radiation therapy usually are in the range of 60
to 70 Gy [2,3]. Wang et al. demonstrated the impor-
tance of dose escalation on overall survival in stage 3
NSCLC patients [4]. The impact of radiation therapy on
local control and survival in SCLC has also been
described [5,6]. The recommended dose schedules for
radiation treatment of SCLC are either 1.5 Gy twice
daily to 45 Gy total dose or 2 Gy once daily to 60-70
Gy according to NCCN Guidelines (Version 2.2012) [7]
In delivering radiation therapy to the lung and med-
iastinum, attention must be devoted to tolerance of nor-
mal tissues. The lung itself is regarded as a very
sensitive organ to radiation damage. Many publications
have addressed the consequences of radiation pneumo-
nitis, which might be a life threatening complication,
and depends on the dose of radiation [8]. The tolerance
of the esophagus and spinal cord to radiation is not less
important. Singh et al. established the threshold point
dose for Grade 3-5 esophageal toxicity at 58 Gy [9].
Published studies have reported a wide range of para-
meters to establish the probability of esophageal radia-
tion related toxicity. Lievens et al. believe that maximal
doses rather than mean doses are more determinant of
late toxicity such as stricture and ulceration [10]. Dose-
volume data for myelopathy in humans treated with
radiotherapy to the spine was reviewed by Kirkpatrick et
al. Using conventional fractionation of 1.8-2 Gy/fraction
to the full-thickness cord, the estimated risk of myelopa-
thy is < 1% and < 10% at 54 Gy and 61 Gy, respectively,
with a calculated strong dependence on dose/fraction
(alpha/beta = 0.87 Gy.) [11].
Given the above considerations, IMRT techniques
were adopted by some centers in the treatment of lung
cancer patients. Comparative evaluation of this techni-
que with commonly used 3D conformal treatment
showed a preference in terms of the target coverage and
the lung exposure and thereby the probability of radia-
tion pneumonitis. Liu et al. advocated reduction of V10
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and V20 for thoracic normal tissues using IMRT. The
percentage of lung volume that received > 20 Gy and
the mean lung dose were reduced for all cases with
reduction for a median of 8% and 2 Gy respectively
[12]. Murshed et al. described the median absolute
reduction of lung volume irradiated to > 10 and 20 Gy
using IMRT as 7% and 10% respectively. This corre-
sponds to a decrease of > 2 Gy in the total lung mean
dose and of 10% in the risk of radiation pneumonitis
[13].
The benefit of single IMRT approaches to treat thor-
acic malignancies was questioned by several authors.
The high incidence of fatal pneumonitis after IMRT
irradiation for mesothelioma was attributed to large
volumes of lung receiving
low doses (V5 > 90%) [14]. Mayo et al. introduced the
notion of hybrid IMRT for treatment of lung and eso-
phageal cancer. They compared concurrently combined
static and IMRT beams with 3D and IMRT plans.
Hybrid plans resulted in smaller total and contra lateral
lung volumes with lower doses than IMRT plans [15].
The new technology of volumetric arc therapy
(VMAT) was also compared with Hybrid- RapidArc
treatment for NSCLC and showed the lowest V20 and
MLDs [16]
We propose that the delivery of radiation therapy with
AP-PA beams followed by IMRT may actually improve
the sparing of normal lung tissue while possibly increas-
ing doses to the mediastinal structures, yet still main-
taining the latter within the range of tolerability. The
hypothesis is based on the fact that with IMRT field
arrangements, opposed beams are not recommended.
Indeed Bortfeld, on behalf of the American Association
of Physicists in Medicine (AAPM, Monograph 29),
admonished that “parallel-opposed beams should be
avoided in IMRT - the reason (being) that parallel
opposed beams add much less beam-shaping potential”
[17].
With “inverse planning” which is embedded in IMRT
techniques the user sets the beams angle arrangements,
and the optimization engine determines the best solu-
tion for the leaf arrangement with corresponding dose
per beam.
Using opposed fields will cause the optimization
engine to be less effective because of the debate regard-
ing which beam will deliver the dose to the target.
Therefore, theoretically, in centrally located lung
tumors more intact lung tissue is irradiated and organs
of the mediastinum are relatively spared in the IMRT
technique. We therefore suggest that older AP-PA tech-
niques not be indiscriminately abandoned for all
patients undergoing definitive irradiation following a
diagnosis of lung cancer.
The combination of AP-PA with the aim of sparing
the lung tissue and IMRT in an attempt to preserve the
esophagus and spinal cord might be considered for
treatment planning.
Methods
Seven patients with centrally-located primary lung can-
cer were assessed for the treatment plans described
above in our department. Four of them had NSCLC and
three- Limited Stage SCLC. There were four men and
three women, age 43 to 70 year old. (mean: 67). The
dose prescribed to the PTV was 60 Gy in fractions of 2
Gy.
PET CT was performed on every patient prior to
simulation. All patients underwent CT simulation; 3
mm slice thickness (Bigbore 120 - Brilliance, Phillps) in
the supine position on the lung board. The instructions
for the PTV delineation were strictly followed in accor-
dance with the ICRU- 62 guidelines [18]. The GTV
included the visible tumor based on the pretreatment
PET CT appearance. Lymph nodes were electively irra-
diated in cases of SCLC. Gross tumor volume (GTV)-to
clinical target volume (CTV) margins of 5 mm were
applied. Margins of 5 mm to 10 mm depending on
tumor location and the vicinity of critical structures
were added to generate the planning target volume
(PTV) primarily in order to account for target motion
[18-20]. Daily cone beam CT guidance was used in
order to minimize set-up errors and to reduce the need
to incorporate larger margins into the PTV.
Organs at risk (OAR) - heart, spinal cord, esophagus
and lungs were delineated by the treating physician. The
spinal cord was delineated for its length in the treat-
ment field. The outer wall of esophagus was contoured
in the length of the treatment field as well. The heart
was delineated from the apex to the base and the lungs
were automatically contoured using the Hounsfield unit
threshold algorithm.
Three plans were subsequently generated using consis-
tent planning parameters such as field arrangements,
optimization parameters and beam weights. First, a 3D
plan using 7-9 conformal beams (XiO, v 4.4 CMS). Sec-
ond, a strict IMRT plan using 7 beams. Third, a plan
that consisted of two sequentially administered techni-
ques: IMRT and AP-PA ("experimental plan”). The dose
calculations were performed using homogeneity correc-
tions and superposition algorithm. Physicians selected
the preferred plan after comparing dose distributions by
carefully assessing the best DVHs with attention to V5,
V10, V20, V30 and V40. Mean dose of the lung DVH,
maximal dose to the esophagus and spinal cord were
also studied. The most frequently selected energy of
photons was 10 MV. The number of the fields per
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planning was seven to nine for the conformal 3D, seven
for IMRT and for the combined technique- seven for
IMRT plus separately prescribed AP-PA fields.
The weighting of the opposed fields against IMRT in
the combined group was equally distributed.
The OAR limitations were as follow: MLD (mean lung
dose) less than 19 Gy, V20- less than 37%, heart (V
heart 50- less than 67%, V heart 60- less than 33%), eso-
phagus D max - less than 66 Gy, spinal cord- D max -
less than 50 Gy). PTV coverage should be at 95% of the
planned dose and the maximal dose less than 107%.
Inhomogeneity corrections were applied to all cases
during the planning process. A super-position calcula-
tion algorithm was used for dose calculation. Daily set
up error correction was managed by the cone beam CT
and laser-assisted patient positioning on the lung board.
The statistical approach was to extract the two-tailed
P-Value via independent T testing, using two-sample
distributions assuming unequal variances. Our hypoth-
esis was that either IMRT or 3D is better than the com-
bined technique and our alternative hypothesis was that
the combined technique is superior.
Results
The PTV dose coverage with heterogeneity correction
was equivalent in all three plans: 95.3 ± 4.9% (STDV),
95.5 ± 5.6%, 94.6 ± 2.3% in 3D, IMRT and combined
(IMRT and AP-PA) plans relatively (Figure 1). The
DVH of the lung in three comparative plans for 3D,
IMRT and combined plans for the total lung -GTV was
as follow: V5- 63.2 ± 8.6%, 63.9 ± 9.2%, 56.6 ± 11.4%;
V10- 53.07 ± 10.1%, 52.3 ± 11.2%, 38.8 ± 9.6%; V20-
27.6 ± 6.7%, 31.1 ± 7.0%, 20.6 ± 2.3%; V30- 14.3 ± 4.6%,
13.36 ± 0.37%, 14.96 ± 1.22% and V40- 8.05 ± 4.62, 5.76
± 2.15 and9.21 ± 1.62 respectively (Figure 2, 3). The
mean dose to the right lung- GTV was 17.27 ± 5.47 Gy,
16.17 ± 4.59 Gy, 13.51 ± 5.42 Gy, respectively. The
mean dose to the left lung - GTV was 12.1 ± 5.53 Gy,
13.27 ± 4.02 Gy, 9.31 ± 5.77 Gy. The maximal dose to
the esophagus was 53.21 ± 3.05, 54.4 ± 4.67, 52.3 ± 4.5
Gy, respectively. Maximal dose to the spinal cord was
42.5 ± 2.9, 39.58 ± 1.2 and 43.7 ± 4.5 Gy respectively.
DVHs and axial plans of the representative techniques
are presented in Figure 3, 4
The number of monitor units was 527 ± 86.7, 669 ±
200.4, 670 ± 226.0 and 237 ± 32 for 3D, sole IMRT,
IMRT and AP-PA parts of combined plan accordingly.
When examining the P-Value we found that there is a
favored statistical outcome when using the combined
technique vs. IMRT and 3D in the V10 and V20 region.
V10 and V20 were 0.025 and 0.019 respectively -
when comparing IMRT and combined techniques, and
0.035 and 0.034 respectively - when comparing 3D and
combined techniques. The difference between the com-
bined technique and IMRT or 3D was not statistically
significant in the V30 area (p = 0.96 and 0.413) and
between combined and 3D in the V40 area (p = 0.706),
whereas it was statistically significant between combined
and IMRT in V 40 in favor of IMRT (p = 0.017) and in
combined and 3D in V5 (p = 0.0001) in favor of com-
bined, respectively. The differences in maximal doses to
spinal cord and esophagus between the experimental
Figure 1 Normalized DVH of PTV and Total Lung - GTV. The graph depicts the relative dose- volume- histogram for the three techniques of
3D, IMRT and combined IMRT + AP-PA after the correction of heterogeneity
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(combined), IMRT and 3D were also not statistically
significant:
P = 0.38 and 0.12 for 3D and IMRT for spinal cord
and 0.14 and 0.238 for esophagus respectively. The data
demonstrate that when using the combined technique
over IMRT or 3D alone, there are better dosimetric
results in terms of OAR.
Discussion
Although used for decades, inherent challenges still exist
in delivering radiation therapy to lung cancer patients.
With prior techniques it was recommended to irradiate
lung tumors with a two-step procedure beginning with
AP-PA fields to 40 Gy, followed by coplanar fields in
deference to spinal cord tolerance [21]. Three dimen-
sional techniques significantly improved the dose deliv-
ery to the target volumes while maintaining normal
tissues within acceptable dose limits. IMRT further opti-
mized results as documented by several authors [12,13].
Arguably, the most important obstacle in achieving
the maximal dose deposition for lung tumors is the lung
itself. Indeed, radiation-related pneumonitis can consti-
tute a fatal disease. In a seminal report, Graham et al.
established V20 as the most important factor in the inci-
dence of the pneumontis [7]. A V20 at 40% is associated
with a 36% incidence of pneumonitis (> grade 2). In our
___ (Solid)      IMRT+AP-PA 
----- (Dashed)  3D
….. (Dotted)    IMRT





Figure 3 Comparative DVHs of PTV and Total Lung - GTV. The graph depicts the relative dose- volume- histogram for the three techniques
of 3D, IMRT and combined IMRT + AP-PA
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hands, the V20 achieved with the combination of IMRT
fields and AP-PA techniques was 21% in contrast to a
V20 of 31% when IMRT was not supplemented by AP-
PA portals. Other parameters such as V5, V10, and V30
have also been found to be determinant in the develop-
ment of clinically significant pneumonitis [22]. V40 is
rarely cited as a prognostic factor for radiation pneumo-
nitis and is determined at 10% as the threshold level
[23]. The results of the combined arm in V40 were
inferior to IMRT, although they still were in the safe
area below 10%.
A controversial issue that is emerging in the IMRT era
is the implication of irradiating larger tissue volumes to
lower doses. Shueng et al. [24] pointed out that some-
times a static set of AP-PA fields can be advantageous
in view of the risks of large amounts of low dose irradia-
tion to non-target organs at risk. Those authors did not
endeavor to synthesize an AP-PA approach together
with IMRT planning as was done herein. Shi et al. [25]
have found that V10 above 50% is associated with a
29.2% risk of radiation pneumonitis. In contrast those
authors saw a 5.7% risk of radiation pneumonitis when
the V10 was maintained below 50%. Of interest, our
experimental plan (i.e., the combination of AP-PA fields
with IMRT techniques) reached a V10 value of 39% as
opposed to a V10 of 53% when “pure” IMRT techniques
were employed.
In our work we studied a clinical model in which the
combination of IMRT and AP-PA techniques were com-
pared to IMRT alone or to 3-D conformal technology
alone. The theoretical rationale of such a combination
exploits the sophisticated dose shaping capabilities of
IMRT coupled with the minimal dose contribution to
normal lung derived as a consequence of AP-PA beam
arrangement. Although the latter point may seem pro-
saic, we maintain that there is simply no substitute for
the normal lung tissue avoidance achieved with rudi-
mentary AP-PA techniques.
In our study we deliberately selected patients with
centrally located tumors to emphasize the difficulties
encountered in planning this common clinical presenta-
tion. In this clinical scenario the irradiation fields signifi-
cantly involve the soft tissue of the mediastinum.
Therefore, the strategy developed herein was to restore
the use of the older technique of AP-PA beam arrange-
ments in the combined treatment plans in order to







































































































Figure 4 Volumetric exposure of the total lung - GTV. The figure depicts the comparative percentage of the total lung - GTV volume
exposure related to the dose of radiation of 5 Gy, 10 Gy, 20 Gy and 30 Gy for three different techniques of the treatment (3D, IMRT and
combined IMRT + AP-PA) grouped together for each dose superlatively
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Conclusions
Our results show that the use of AP-PA field orientation
followed by IMRT offers benefit in terms of critical lung
volume irradiation while maintaining the esophagus and
the spinal cord within tolerable limits.
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